Celsion, Corp. (NASDAQ:CLSN) Tries to Regain Levels before Crash
Celsion, Corp. (NASDAQ:CLSN) is yet another ambitions biotechnological company cut short by a sudden reversal of fortune. Just on the verge of a stage III trial with expected positive outcomes, CLSN crashed from $4.30...